The Basics of Medicare for Ryan White Program Clients
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
The Alabama Quality Management Group (AQMG) is a consortium of quality leaders representing all Alabama RWHAP Part C and D clinics, over 80% of Alabama's HIV-diagnosed population. Data for Care Alabama (D4C-AL), a CDC-funded retention-in-care project, uses risk-stratification based on missed visits. It is currently being implemented at one site but will continue to be implemented over time.
Resource (Conference Presentation) updated 09/14/2023
Learn how to develop, plan, and implement an organization-wide ECHO model to fully integrate HIV/HCV care and treatment into primary care centers and create wider access for patients with less barriers to care.
Resource (Conference Presentation) updated 09/14/2023
A clinic-based substance abuse screening and treatment program is described. Using the Screening, Brief Intervention, and Referral to Treatment model, this provides annual proactive screening of alcohol/drug use, with a brief provider response and a follow-up motivational interviewing brief intervention, with treatment provided by an embedded provider.
Resource (Conference Presentation) updated 09/14/2023
Oklahoma has been classified by the Department of Health and Human Services as one of the seven states with a high rural HIV burden. Test-and-treat protocols are feasible within high-volume HIV clinics which serve rural and underserved communities to minimize the time to the first appointment to decrease time to viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
Among people with HIV who also inject drugs, an estimated 80 to 90 percent are coinfected with Hepatitis C (HCV.) This panel will provide updates on screening and referral activities and demonstrate how community and city partners are overcoming barriers to HCV care among PWID.
Resource (Conference Presentation) updated 09/14/2023
This session will discuss the implementation, outcomes, and future directions associated with the Health Services Center, Inc. Behavioral Health Co-location (BHC) Project. HSC is the sole provider of free HIV and Hepatitis C (HCV) services to a population facing multiple barriers to care (e.g., poverty, education and stigma) in a largely rural 14-county area of northeast Alabama.
Resource (Conference Presentation) updated 09/14/2023
Boston Healthcare for the Homeless Program will share its innovative approach toward the micro-elimination of Hepatitis C (HCV) for homeless-experienced people with HIV. Team members will share data around cure rates, reinfection, and engaging with marginalized patients, and discuss leveraging existing Ryan White infrastructure and resources for such efforts.
Resource (Conference Presentation) updated 09/14/2023
Panelists will describe collaborative prevention and support services provided to people with HIV and/or hepatitis from incarceration to re-entry. Services addressing social determinants of health are provided in corrections facilities and upon release. Panelists include the program director, staff from a correctional medical facility, and community-based organizations working inside and outside of correction facilities.
Resource (Conference Presentation) updated 09/14/2023
The Marketplace Open Enrollment period lasts only six weeks in most states, and RWHAP programs face challenges in ensuring eligible clients are enrolled or renew their coverage. Participants will gain new strategies for creating effective enrollment partnerships as well as how to prepare staff, partners, and clients for Open Enrollment.
Resource (Conference Presentation) updated 09/14/2023
Ending the HIV Epidemic: A Plan for America provides an incredible opportunity for jurisdictions to assess their health systems, prevention activities, and linkage to care programs. It is important that health departments create innovative programs and examine how this initiative can be used to address viral hepatitis as well.
Resource (Conference Presentation) updated 09/14/2023
Explore how to leverage data visualizations created in Tableau in order to increase clinician access to HIV quality data and thereby motivating provider teams to improve quality measures. The session will also discuss an antiretroviral treatment (ART) dashboard created in Tableau.
Resource (Conference Presentation) updated 09/14/2023
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approval of these drugs. There will be a brief overview of the ATLAS and FLAIR studies, discussion of the medications, and an outline of the potential impact of the regimens on care delivery models, providers, patients, and payers if they are approved.
Resource (Conference Presentation) updated 09/14/2023
The HCV Consultation Line (HEPline) has received multiple cases involving Hepatitis C (HCV) treatment interruptions with prescribers asking for guidance on best approaches. This presentation reviews representative HCV cases where treatment interruptions provide lessons in improving systems of care to prevent treatment lapses and optimize the chance of HCV cure.
Resource (Conference Presentation) updated 09/14/2023
Rapid initiation of antiretroviral therapy (ART) after diagnosis can increase the number of patients arriving for appointments, shorten time to viral suppression, and promote health equity. The presenters share key lessons learned through the implementation process at a large HIV clinic in the South with the theme of partnerships.
Resource (Conference Presentation) updated 09/14/2023
In December 2016 CrescentCare began linking individuals newly diagnosed with within 72-hours through the CrescentCare START Initiative. We compared linkage and viral suppression between those under and over 24 years old. We found similar successful outcomes for both age cohorts in our intervention.
Resource (Conference Presentation) updated 09/14/2023
Implementation of rapid antiretroviral therapy (ART) initiation is beset with clinical and process challenges. Three clinical providers will share their lessons learned from developing a program and delivering care in various care settings (pediatric, adult, and walk-in clinic).
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 12/11/2023
Rapid antiretroviral treatment (ART) initiation in the United States remained 'investigational' until the update in the Department of Health and Human Services guidelines (December 18, 2019). Centers for AIDS Research (CFARs) in D.C., the San Francisco Bay area, and Baltimore will share how they are working with their health departments and implementing partners, including Ryan White-funded clinics to address rapid ART implementation strategies.
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 12/11/2023